Because transplantation of wild type mouse bone marrow alleviated the change, the authors concluded that LRG1 production from heart-infiltrating myeloid cells improves local angiogenesis, suppresses cardiac remodeling and protects against cardiovascular diseases. Here, LRG1 is linked to cardiovascular disorder.